Meeting Banner
Abstract #0404

Glioma 2HG threshold setting based on normal appearing white matter increases the diagnostic value of 3D MEGA-LASER for IDH mutation detection

Marzena Wylezinska-Arridge1,2, Enrico De Vita2,3, Laura Mancini1,2, Ovidiu Andronesi4, Wolfgang Bogner5, Bernhard Strasser4, Tarek Yousry1,2, John Thornton1,2, and Sotirios Bisdas1,2
1Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom, 2Institute of Neurology, University College London, London, United Kingdom, 3Department of Biomedical Engineering. School of Biomedical Engineering and Imaging Sciences, Kings College London, London, United Kingdom, 4Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States, 5High Field MR Centre, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria

It has been established that 2-hydroxyglutarate (2GH) MRS is important for non-invasive diagnosis of isocitrate dehydrogenase (IDH) status that holds prognostic value for the patient and is important for treatment planning. The purpose of this work was to investigate whether the threshold determination for identification of IDH mutation could be improved by using ‘control’ spectra from normal-appearing white matter, NAWM , in multi-voxel 3D MEGA-LASER acquisitions. The proposed approaches to threshold determination for 2HG detection in the tumour voxels provided increased sensitivity and specificity as compared with the cut-off thresholds based on CRLB% relative error.

This abstract and the presentation materials are available to 2020 meeting attendees and eLibrary customers only; a login is required.

Join Here